The Effect of Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibitors on Cardiometabolic Profile; Beyond the Hypoglycaemic Action
Crossref DOI link: https://doi.org/10.1007/s10557-017-6724-3
Published Online: 2017-04-25
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lioudaki, Eirini
Androulakis, Emmanouil S.
Whyte, Martin
Stylianou, Konstantinos G.
Daphnis, Eugenios K.
Ganotakis, Emmanouil S.
License valid from 2017-04-01